Incyte: Don’t Worry…Be Happy!
June 06, 2017 at 12:47 PM EDT
Shares of this closely-watched drug maker fell again Tuesday after data release at a major medical conference about its experiential cancer therapy raised questions. But an analyst with Credit Suisse isn't concerned. Here's why.